Stock PAX PAXMAN AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Paxman AB

Equities

PAX

SE0009806284

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Stockholm
Other stock markets
 06:59:47 2024-04-30 am EDT 		5-day change 1st Jan Change
35.8 SEK -4.53% Intraday chart for Paxman AB +1.99% -2.72%
Jan. 15 Paxman AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Paxman AB Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI

Valuation

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Capitalization 1 406.7 1,236 819.4 680.6 680.6 -
Enterprise Value (EV) 1 406.7 1,236 798.3 699.7 638.6 583.6
P/E ratio -21.2 x -89 x -79.8 x 83.6 x 19.9 x 8.14 x
Yield - - - - - -
Capitalization / Revenue - - 5.62 x 3.33 x 2.33 x 1.7 x
EV / Revenue - - 5.47 x 3.33 x 2.19 x 1.46 x
EV / EBITDA - - 49.4 x 22.4 x 9.46 x 4.71 x
EV / FCF - - -22.8 x - 20.6 x 10.6 x
FCF Yield - - -4.38% - 4.85% 9.42%
Price to Book - - - - - -
Nbr of stocks (in thousands) 16,013 19,013 19,013 19,012 19,012 -
Reference price 2 25.40 65.00 43.10 35.80 35.80 35.80
Announcement Date 2/26/21 2/25/22 2/24/23 1/15/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net sales 1 - - 145.9 210.1 292 401
EBITDA 1 - - 16.18 31.23 67.5 124
EBIT 1 - - -1.243 12.62 45.1 99
Operating Margin - - -0.85% 6.01% 15.45% 24.69%
Earnings before Tax (EBT) 1 - - -8.562 7.968 43 106
Net income 1 -19.19 -12.78 -10.32 8.239 34 84
Net margin - - -7.07% 3.92% 11.64% 20.95%
EPS 2 -1.200 -0.7300 -0.5400 0.4400 1.800 4.400
Free Cash Flow 1 - - -35 - 31 55
FCF margin - - -23.99% - 10.62% 13.72%
FCF Conversion (EBITDA) - - - - 45.93% 44.35%
FCF Conversion (Net income) - - - - 91.18% 65.48%
Dividend per Share - - - - - -
Announcement Date 2/26/21 2/25/22 2/24/23 1/15/24 - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q2 2021 Q3 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 22.76 23.27 - 40.74 42.32 50.97 61.23 55.59 57 64 80 77
EBITDA 1 -0.479 -1.281 - 12.77 2.685 6.051 13 9.496 10 14 23 21
EBIT 1 -3.819 -4.795 - 8.342 - 1.585 8.131 4.563 4.6 8.2 16.9 15.5
Operating Margin -16.78% -20.61% - 20.47% - 3.11% 13.28% 8.21% 8.07% 12.81% 21.12% 20.13%
Earnings before Tax (EBT) - - - - - - - - - - - -
Net income - - 4.652 - - - - - - - - -
Net margin - - - - - - - - - - - -
EPS 2 - - 0.2400 -0.5100 -0.1300 0.2700 0.3900 -0.0900 0.2000 0.3000 0.7000 0.6000
Dividend per Share - - - - - - - - - - - -
Announcement Date 8/27/21 11/19/21 11/18/22 2/24/23 5/24/23 8/24/23 11/17/23 1/15/24 - - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - -
Net Cash position 1 - - 21.1 19 42 97
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - - -35 - 31 55
ROE (net income / shareholders' equity) - - -8.6% 15% 24% 42%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share - - - - - -
Cash Flow per Share - - - - - -
Capex 1 - - 27.3 15 6 8
Capex / Sales - - 18.74% 6.94% 2.05% 2%
Announcement Date 2/26/21 2/25/22 2/24/23 1/15/24 - -
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Ratings for Paxman AB

Trading Rating
Investor Rating
ESG Refinitiv
D
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
PAXMAN AB Stock Paxman AB
-2.72% 61.97M
ABBOTT LABORATORIES Stock Abbott Laboratories
-3.61% 184B
MEDTRONIC PLC Stock Medtronic plc
-2.31% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.46% 67.78B
DEXCOM, INC. Stock DexCom, Inc.
+0.01% 50.66B
CENCORA, INC. Stock Cencora, Inc.
+10.97% 47.64B
HOYA CORPORATION Stock Hoya Corporation
+4.60% 41.12B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+0.90% 26.3B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+1.42% 26.04B
TERUMO CORPORATION Stock Terumo Corporation
+15.06% 25.4B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. PAX Stock
  4. Financials Paxman AB